In a patient with hyperthyroidism presenting with raised jugular venous pressure, syncope, and palpitations, what is the immediate inpatient management?

Immediate Management of Hyperthyroidism with Cardiovascular Decompensation

This patient requires immediate beta-blockade and urgent antithyroid drug therapy, with strong consideration for ICU admission given the presentation of raised JVP, syncope, and palpitations suggesting high-output heart failure or impending thyroid storm.

Critical Initial Assessment

The combination of hyperthyroidism with raised JVP and syncope indicates severe cardiovascular compromise—either high-output heart failure, atrial fibrillation with rapid ventricular response, or potentially thyroid storm. This presentation demands immediate intervention to prevent mortality.

Immediate Pharmacologic Management

Beta-Blockade (First Priority)

• Start beta-blockers immediately for any hyperthyroid patient with cardiovascular disease, heart rate >90 bpm, or symptomatic thyrotoxicosis 1
• Critical caveat: Assess cardiac function FIRST before administering beta-blockers—if severe heart failure is present, non-cardioselective beta-blockers can precipitate cardiogenic shock 2
• Perform urgent echocardiography if possible before beta-blocker administration in patients with raised JVP
• If heart failure is present, consider cardioselective beta-blockers (e.g., metoprolol) at lower doses with careful titration

Antithyroid Drug Therapy

• Initiate methimazole immediately at high doses (20-40 mg daily) for severe symptomatic hyperthyroidism 1
• Do not delay antithyroid drugs while awaiting diagnostic workup
• If thyroid storm is suspected (use Burch-Wartofsky score), add:
  • Corticosteroids (dexamethasone 2 mg every 6 hours or hydrocortisone 100 mg every 8 hours) 3, 4
  • Iodine solution (Lugol's iodine or saturated solution of potassium iodide) but ONLY after antithyroid drugs have been started (wait at least 1 hour) 3, 5

Diagnostic Workup (Concurrent with Treatment)

Obtain immediately:

• ECG: Look for atrial fibrillation, conduction abnormalities, or evidence of ischemia
• Echocardiogram: Assess for heart failure, valvular disease, pulmonary hypertension
• Thyroid function tests: Free T4, T3, TSH
• Complete blood count: Baseline before antithyroid drugs
• Electrolytes: Hypokalemia can occur with thyrotoxic periodic paralysis
• Troponin and BNP: If cardiac decompensation suspected

Critical Monitoring and Escalation

ICU/High-Dependency Unit Admission Criteria:

• Syncope with hyperthyroidism suggests severe hemodynamic instability
• Raised JVP indicates volume overload or right heart strain
• Consider thyroid storm if Burch-Wartofsky score >45 3, 2

Refractory Cases:

• If cardiogenic shock develops despite standard therapy, consider mechanical circulatory support (VA-ECMO) 5
• Levosimendan may be more effective than dobutamine in patients on prolonged beta-blockade 5
• Emergency thyroidectomy may be necessary for refractory thyroid storm after initial stabilization 3

Common Pitfalls to Avoid

1. Do NOT give beta-blockers blindly without assessing cardiac function—this can precipitate cardiogenic shock in decompensated heart failure 2
2. Never give iodine before antithyroid drugs—iodine can worsen thyrotoxicosis if given first (Jod-Basedow phenomenon)
3. Do not assume tachycardia—hyperthyroidism can rarely present with bradycardia or heart block, particularly with syncope 6, 7
4. Avoid non-cardioselective beta-blockers (propranolol) if heart failure is present

Definitive Management Planning

Once stabilized:

• Determine etiology (Graves' disease vs. toxic nodular goiter vs. other)
• Plan definitive therapy: radioactive iodine, continued antithyroid drugs, or thyroidectomy
• Optimize comorbid conditions before definitive treatment 1

The key to survival in this presentation is aggressive early treatment with beta-blockade (after cardiac assessment) and high-dose antithyroid drugs, with low threshold for ICU admission and multidisciplinary involvement of endocrinology, cardiology, and critical care.